Science

Riken President Ryoji Noyori, center, expresses regret at a press conference in Tokyo on April 1.

Scientific 'paradise' shaken by STAP scandal

TOKYO -- Riken, Japan's largest comprehensive research institution, faces a quandary as it has been embroiled in a debilitating scandal involving Haruko Obokata's controversial research into stimulus-triggered acquisition of pluripotency (STAP) cell ...

  • STAP cells hold promise despite problems with papers: co-author

    OSAKA -- Research papers detailing a new method for creating stem cells should be retracted because of credibility issues, but the studies are worth exploring further, a co-author of the controversial research papers said Wednesday. Yoshiki Sasai...

  • Controversial stem cell researcher's instructor to meet press Wed.

    TOKYO (Kyodo) -- A co-author of controversial research papers on STAP cells will hold a press conference Wednesday afternoon in Tokyo, the Riken institute said Tuesday. Yoshiki Sasai, deputy director of the Riken Center for Developmental Biology...

  • Riken says STAP cells only partially created by third party

    OSAKA (Kyodo) -- The government-funded Riken institute said Monday a person other than the co-authors of controversial research papers has partially generated so-called STAP cells, adding that does not support lead author Haruko Obokata's claim last ...

  • STAP science anything but settled as researcher rebuffs fraud accusation

    TOKYO -- A Japanese scientist accused of faking research on stem cell creation apologized Wednesday for "mistakes" in her reports but insisted her findings are sound. Haruko Obokata's refusal to bow to her critics opens a new chapter in the scandal -...

  • Japanese researcher stresses validity of STAP cells

    OSAKA (Kyodo) -- The Japanese researcher accused by the government-funded Riken institute of falsifying and fabricating parts of her purportedly groundbreaking STAP stem cell papers said Wednesday that her findings remain valid. Haruko Obokata t...

  • Investigation into STAP cell papers 'inadequate': Obokata lawyer

    OSAKA (Kyodo) -- A researcher accused of falsifying data on potentially trailblazing stem cell research is set to appeal the findings by the research institute's investigative panel as "inadequate," her lawyer said Saturday. Haruko Obokata, the l...

  • Riken needs to dig deeper on STAP cell scandal

    TOKYO -- Haruko Obokata at Japan's Riken research institute has been found guilty of misconduct by an in-house committee investigating allegations the biologist falsified results in papers that claimed her team had developed a new type of stem cells....

  • Embattled lab to try growing STAP cells from scratch

    TOKYO -- The government-backed Riken research institute will spend the next year trying to verify whether stem cells can actually be created using a technique that its scientists touted in papers that have come under fire. The cells in question a...

  • Stem cell researcher to fight Riken's findings of misconduct

    OSAKA -- The lead author of disputed stem cell papers rejected the conclusion by Japan's leading research institute that there had been misconduct, setting the stage for an appeal. Riken's investigative committee released its final report Tuesday...

  • Internet puts scientific papers to the test

    TOKYO -- Scientists are facing even greater scrutiny than peer review as the Internet gives experts and amateur enthusiasts around the world the tools to easily analyze new research. The scandal over the so-called stimulus-triggered acquisition o...

  • Japanese institute said it found misconduct in stem-cell studies

    TOKYO (Dow Jones) -- Japan's leading research institute on Tuesday said it found evidence of scientific misconduct in disputed studies on stem cells led by one of its scientists. Riken, a prestigious, government-funded institute, has been investi...

  • Japan to mandate ethics training for budding researchers

    TOKYO -- Responding to alleged plagiarism in high-profile papers from Japanese scientists, the Education Ministry has decided to require ethics instruction for graduate students and researchers at universities and research institutions. The paper...

  • Sekisui Plastics filter helps fight the eye-strain 'blues'

    TOKYO -- With people spending more time staring at their PCs and smartphones, eye strain is becoming a growing problem. A big cause of the discomfort is the blue light emitted from the screens. To combat this problem, Sekisui Plastics of Japan ha...

  • Breakthrough sheds light on birth of the universe

    TOKYO -- Scientists have announced the first ever detection of so-called gravitational waves that are believed to have been generated in the first fraction of a second after the universe sprang into existence 13.8 billion years ago. The disc...

  • Mathematical models bring scientists closer to cracking cancer's code

    TOKYO -- Scientists at Japanese universities are delving deep into data to aid the fight against cancer. Using mathematical models, they are shedding light on how cancer cells spread.

  • Still no light at end of tunnel for nuclear fusion project

    WASHINGTON -- The international nuclear fusion project known as ITER has been delayed yet again, raising concerns that mounting costs may prevent the futuristic energy venture from ever being realized. ITER's goal is to demonstrate the feasibilit...

  • Yamanaka to distribute iPS cells for testing this year

    OSAKA -- Induced pluripotent stem cells will be provided to research institutions for evaluation of their safety, Kyoto University professor Shinya Yamanaka said.

  • Japan to measure air-fouling 'black carbon' from space

    TOKYO -- The global scientific community will get a better handle on the behavior of an atmospheric pollutant known as black carbon when Japan launches the successor to its current Greenhouse Gases Observing Satellite in fiscal 2017. The new inca...

  • Biotech companies yo-yo as STAP scandal grows

    TOKYO -- The scandal engulfing Japan's Riken institute over a flawed stem cell study is also rocking the stock market. Biotechnology companies have seen their share prices swing wildly as excitement over the findings -- which promised a surprisingly ...